Bleomycin induced Flagellate Erythema: A Rare and Unique Drug Rash
Journal Title: GUJARAT CANCER SOCIETY RESEARCH JOURNAL - Year 2017, Vol 19, Issue 2
Abstract
Bleomycin has been used most commonly in the treatment of Hodgkin’s lymphoma, certain germ cell tumors and for the sclerosis of recurrent pleural effusions. Bleomycin toxicity predominantly affects the skin and lungs. Skin toxicity includes Raynaud’s phenomenon, hyperkeratosis, nail-bed changes and palmoplantar desquamation. Flagellate erythema is an unusual rash occurring specifically during bleomycin use. In the present study, we report a case of bleomycin-induced flagellate erythema in a patient with Hodgkin’s lymphoma (HL). A 45-year-old male was diagnosed with stage IV Hodgkin’s lymphoma and treated with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy. After 3 months from the initiation of treatment, the patient subsequently developed a generalized pruritus and erythematous linear rash that was most prominent on the trunk, and upper and lower extremities. The patient was commenced on a short course of low-dose oral prednisolone, 20 mg daily, and antihistaminics. Consequently, bleomycin was withheld from the patient’s treatment regimen. The present study describes the case, along with a review of the associated literature.
Authors and Affiliations
Rakesh Patil, Harsha Panchal, Sonia Parikh, Preetam Jain, Ekta Vala, Salil Patkar, Alok Ranjan
Time Trends of Breast Cancer Incidence of Two Periods in Ahmedabad Urban Agglomeration Area
Breast cancer is the leading female cancer across the globe. It was thought that due to higher rural population in India, leading female cancer is cervical cancer. But as years passes and due to the effect of urbanizatio...
Global Response to Combat Antimicrobial Resistance: Back to Basics
“O Goddess Maa Sarasvati! I begin my work with Salutations to You, You the giver of boons and the one who fulfills all desires. May there always be accomplishments for all of us! May we be relieved by the “menace” of inf...
Myths and Facts about Palliative Care
Palliative care has been included in the WHO definition of Universal Health Coverage (UHC). This means that palliative care will be included in discussions as the WHO prioritizes UHC.1 Myths and misinformation around hos...
Shri Hiralal Bhagwati Interventional Therapy Center
Shri Hiralal Bhagwati Interventional Therapy Center
The Impact of Obesity on Surgery in Gynaecologic Oncology: Our Experience
Surgery represents the mainstay in the treatment of gynecological cancers. It is believed to be more difficult in obese patients and increases the incidence of intraoperative and postoperative complications in these pati...